Show simple item record

dc.contributor.authorVela Benavides, Fátima 
dc.contributor.authorEzzanad, Abdellah 
dc.contributor.authorHunter, Alan Christy
dc.contributor.authorMacías Sánchez, Antonio José 
dc.contributor.authorHernández Galán, Rosario 
dc.contributor.otherQuímica Orgánicaes_ES
dc.contributor.otherTecnologías del Medio Ambientees_ES
dc.date.accessioned2023-01-19T13:18:20Z
dc.date.available2023-01-19T13:18:20Z
dc.date.issued2022-07
dc.identifier.issn1424-8247
dc.identifier.urihttp://hdl.handle.net/10498/27767
dc.description.abstractLathyrane diterpenoids are one of the primary types of secondary metabolites present in the genus Euphorbia and one of the largest groups of diterpenes. They are characterized by having a highly oxygenated tricyclic system of 5, 11 and 3 members. These natural products and some synthetic derivatives have shown numerous interesting biological activities with clinical potential against various diseases, such as cytotoxic activity against cancer cell lines, multi-drug resistance reversal, antiviral properties, anti-inflammatory activity and their capability to induce proliferation or differentiation into neurons of neural progenitor cells. The structure of the lathyrane skeleton could be considered privileged because its framework is able to direct functional groups in a well-defined space. The favorable arrangement of these makes interaction possible with more than one target. This review aims to highlight the evidence of lathyranes as privileged structures in medicinal chemistry. Chemical structures of bioactive compounds, the evaluation of biological properties of natural and semisynthetic derivatives, and the exploration of the mechanisms of action as well as target identification and some aspects of their targeted delivery are discussed.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourcePharmaceuticals, Vol. 15, Núm. 7es_ES
dc.subjectlathyranees_ES
dc.subjectbiological activityes_ES
dc.subjectditerpenees_ES
dc.subjectEuphorbiaes_ES
dc.titlePharmacological Potential of Lathyrane-Type Diterpenoids from Phytochemical Sourceses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/ph15070780
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-099908-B-C22/ES/DITERPENOS COMO NUEVOS MODELOS DE FARMACOS EN TERAPIAS DE REGENERACION NEURONAL/es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/Junta de Andalucía//P18-RT-2655es_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This work is under a Creative Commons License Atribución 4.0 Internacional